NCT02219828View on ClinicalTrials.gov

AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP)

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions
Idiopathic Recurrent Pericarditis
Interventions
DRUG

Anakinra

2mg/Kg daily sc up to 100mgday as maximum dose

DRUG

Placebo

Placebo

Trial Locations (3)

10141

Cardiology Dpt, Maria Vittoria Hospital, Torino

16100

Pediatric Dept. Ospedale Gaslini, Genova

24100

Internal Medicine Division, OSpedale Papa Giovanni XXIII, Bergamo

All Listed Sponsors
lead

Massimo Imazio

OTHER

NCT02219828 - AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP) | Biotech Hunter | Biotech Hunter